Program Overview and Resources
We cordially invite you to join a select group of specialists for an interactive and educational platform in the series The Changing Perception of Reversibility and the Treatment of COPD. This virtual programming is specialty-focused. Only specialists will be permitted to register and participate in these programs.The Changing Perception of Reversibility and the Treatment of COPD
After participating in this interactive discussion, participants will be able to* To review the professional guidelines and clinical data, which demonstrate that airflow obstruction in COPD is at least partially reversible
* To examine studies that show bronchodilators can improve lung function in COPD patients
* To understand how a patient's reversibility status may vary over time and in response to different types of bronchodilators
Resources
* Symbicort full Prescribing Information
AstraZeneca fully supports and abides by the PhRMA Code on Interactions with Health Care Professionals. AstraZeneca cannot accommodate or pay for the cost of a spouse or other guest of a health care professional. As such, this program is open to invitees only. If you are a prescriber and/or a Federal, State or institution employee, you may be subject to laws, regulations or rules which prohibit or limit gifts, meals or items of value you may receive. We ask that you comply with any restrictions that govern your receipt of gifts, meals or items of value.
AstraZeneca will neither recommend, endorse, or support the submission of this promotional program for CE credits.
